Apple continues to be attempting to overturn the ban on the Apple Watch blood oxygen sensor

Apple is making one other try and attraction the commerce ban that compelled it to take away the blood oxygen sensor from its smartwatches, Reuters reports. The corporate was compelled to take away the characteristic in 2024, following a decision from the International Trade Commission (ITC) in 2023 that banned gross sales of the Apple Look ahead to violating well being tech startup Masimo’s patents.

The US Court docket of Appeals for the Federal Circuit heard new arguments from Apple and Masimo’s legal professionals on Monday over the legality of the unique ITC ban. Apple’s argument is that the very fact Masimo was growing its personal smartwatch when Apple launched the Apple Watch Series 6 in 2020 — the primary of the corporate’s wearables with a blood oxygen sensor — should not be sufficient to justify the ban. Masimo disagrees.

The appeals courtroom has heard the company’s arguments before, and even briefly paused the trade ban in December 2023 whereas the ITC thought of Apple’s request for an extended pause. Finally, the ITC dominated in Masimo’s favor and denied Apple’s request. Apple removed the blood oxygen sensor in 2024 so it may restart gross sales of the Apple Watch Collection 9 and Apple Watch Extremely 2 within the US.

The businesses’ combat goes past simply the blood oxygen sensor — Masimo’s smartwatches had been, paradoxically, found to infringe on Apple patents — however clearly Apple is hung up on the characteristic. The corporate’s blood oxygen sensor was by no means as correct as the heart beat oximeters utilized in a health care provider’s workplace, however it was a part of a reasonably complete suite of heart health features on the smartwatch. It is totally attainable Apple desires to reintroduce it in its watches as a part of an much more formidable well being characteristic down the highway.